Trasylol therapy of haemorrhage in surgical patients.
D000037:Abruptio Placentae / Q000188:drug therapy; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000032:analysis; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy; D011247:Pregnancy
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D006493:Heparin; D007611:Aprotinin